Medicapedia ESENCA
Image of Isolation of growth hormone
Image: Wikimedia Commons

Isolation of growth hormone

1921 · discovery of the pituitary's effect on growth

Share:FacebookWhatsApp

At the beginning of the twentieth century, it was known that some growth disorders, such as dwarfism and gigantism, were linked to the pituitary, a pea-sized gland at the base of the skull. However, nobody had yet identified the substance responsible or shown that it could be isolated. Children with short stature caused by a hormone deficiency had no effective treatment, and endocrinology, the branch of medicine that studies hormones, was still in its early stages.

In 1921, Herbert McLean Evans, working at the University of California at Berkeley with his team, injected extracts of the anterior pituitary into young rats. The animals grew more than expected and reached maturity differently from the control group. The experiment suggested that the gland contained an active principle able to stimulate body growth. Later, Choh Hao Li joined this research and spent years purifying the substance and studying its chemical properties, a demanding task because the hormone is present in very small amounts within the tissue.

The work met resistance. The extracts were impure, their activity varied from batch to batch, and at first it was hard to prove that the growth effect came from a single hormone rather than a mixture of pituitary substances. Supplies were also limited, since the tissue came mainly from animals and from human cadavers.

Over time, purification allowed children with growth hormone deficiency to be treated with extracts of human origin, and later production through recombinant DNA technology gave rise to somatropin. Today it is known that growth hormone is a polypeptide of 191 amino acids, produced by cells of the anterior pituitary, that regulates growth, metabolism and body composition. That early discovery, made with rats and rudimentary extracts, opened the way to understanding how this gland controls human development.

Key dates

  • 1921 Evans shows in rats that an extract of the anterior pituitary stimulates growth.
  • 1940s Li advances the purification and characterisation of the hormone.
  • 1958 Treatment of children with growth deficiency using extracts of human origin begins.
  • 1992 Recombinant DNA somatropin is introduced, as noted in the reference text.

Key figures: Herbert McLean Evans y Choh Hao Li

Sources

Original Medicapedia text based on:

Last updated: 5 November 2026 · How Medicapedia is made

A project by Alejandro Rosàs Navarro, family physician and specialist in preventive medicine and public health. Spotted a mistake? Write to info@medicapedia.org.